BioSpace News Archive

Deals

Allogene Therapeutics Announces Pricing of Initial Public Offering of $18.00 Per Share

Allogene Therapeutics, Inc. today announced the pricing of its initial public offering of 18,000,000 shares of its common stock at a price to the public of $18.00 per share.

October 10, 2018
·
2 min read
Business

Facing Addiction With NCADD Honored Joe And Marjorie Walsh, And Matthew And Jennifer Harris, At Their Annual Gala, Monday October 8 At New York’s Iconic Rainbow Room

Honors Were Presented By Sir Ringo Starr, Lady Barbara Bach Starkey, And Adebayo Ogunlesi, With Keynote Remarks From Boston Mayor Marty Walsh And Tribute Performances By Vince Gill And Michael McDonald

October 10, 2018
·
6 min read
Deals

Audentes Therapeutics Announces Pricing of Public Offering of 5,200,000 Shares of Its Common Stock

Audentes Therapeutics, Inc. today announced the pricing of its underwritten public offering of 5,200,000 shares of its common stock at a price to the public of $29.00 per share.

October 10, 2018
·
3 min read
Mitsubishi Electric Testing Wind LIDAR and Water Vapor DIAL, Including Laser Amplifier with World’s Highest Output, for Early Forecasting of Torrential Rain

Will facilitate better forecasting of torrential rain

October 10, 2018
·
2 min read
Business

Anatara Lifesciences Ltd (ASX:ANR) 2018 Annual Report

Anatara Lifesciences is pleased to release its Annual Report, for the year ended 30th June 2018.

October 10, 2018
·
3 min read
Recipharm releases first serialised products to Europe

Recipharm, a leading contract development and manufacturing organisation (CDMO), has released its first serialised products to Europe from its facilities in Lisbon, Portugal and Stockholm, Sweden.

October 10, 2018
·
3 min read
Arran Chemical Company Completes Stage II of its Strategic Plan “ADAPT”

Completion of multi-million Euro expansion of manufacturing capacity and deployment of next generation production technologies

October 10, 2018
·
2 min read
Business

Bionure appoints Dr. Laurent Nguyen as CEO

The neuroprotection biotech also strengthens its scientific team with the arrival of Dr. Amit Bar-Or, a multiple sclerosis specialist, to the Scientific Advisory Board

October 10, 2018
·
3 min read
Business

Gotham Therapeutics Launches in New York City with $54 Million Series A Financing

Gotham Therapeutics launched in New York with a $54 million Series A financing. The focus is on a subgroup of RNA metabolism called epitranscriptomics. This involves the biochemical modifications of RNA within a cell, which have an impact on gene expression.

October 10, 2018
·
2 min read
·
Mark Terry
Job Trends

Pfizer Establishes Executive Team to Support New CEO Albert Bourla

As the timeline shortens for Albert Bourla to take over the reins of Pfizer from Chief Executive Officer Ian Read, the company has released details of the new senior management team that will continue to lead the company forward.

October 10, 2018
·
3 min read
·
Alex Keown